Invizyne

Monrovia, United States Founded: 2014 • Age: 12 yrs Listed
Enzymatic bioconversions are designed for cannabinoid product synthesis.

About Invizyne

Invizyne is a company based in Monrovia (United States) founded in 2014 by Paul Opgenorth, Tyler Korman, and James Bowie. The company has 16 employees.

  • Headquarter Monrovia, United States
  • Employees 16
  • Founders Paul Opgenorth, Tyler Korman, James Bowie
  • Stage Public
  • Sectors
    Consumer
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website invizyne.com
  • Social LinkedIn
Key Metrics
  • Latest Funding Round
    $243.53K (USD), Grant

    Feb 2024

  • Investors
  • Employee Count
    16

Funding Insights of Invizyne

  • Total Rounds 5
  • Last Round Grant β€” $243,527
  • First Round $2.28M

    (Jul 2019)

  • Investors Count 1

All 5 funding rounds of Invizyne with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2024$243,527Grant––
Aug 2022$496,177Grant––
Sep 2021$2.05MGrant––
Apr 2020$150,000Grant––
Jul 2019$2.28MGrant––
Valuation history

1 investors in total: 1 institutional.

Investors in Invizyne

Invizyne has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include OSTI.GOV.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Scientific and technical information is managed and disseminated by OSTI.GOV.
–osti.govOak Ridge, United States
Premium access

Investor details for Invizyne

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Invizyne

9 people are tracked at Invizyne (8 in leadership, 1 in team); the tracked headcount is 16.

NameRoleGroup
Paul Opgenorth
Co-FounderLeadership
Tyler Korman
FounderLeadership
James Bowie
Co-FounderLeadership
Mo Hayat
CEOLeadership
John Billingsley
DirectorLeadership
Damien Perriman
Chief Commercial Officer (cco)Leadership
Zachary Karl
Vice President, Head Of Business DevelopmentLeadership
Michael Heltzen
Chief Executive OfficerLeadership
Michael Burns
EVP Energy TransitionTeam
Premium access

Complete people profiles for Invizyne

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Invizyne

4 dated milestones of Invizyne across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Invizyne is founded.
  2. Funding First funding round of $2.3M.
  3. Funding Latest funding round, Grant, of $244K.
  4. IPO Lists on the stock exchange (IPO).

Similar companies to Invizyne

10 companies that operate in the same segment as Invizyne (Cannabis Platforms & Ecosystem Services), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Legal medical and recreational cannabis products are manufactured.
2016Ann Arbor, Michigan, United StatesUSD 89.95 M–214
Cannabis is cultivated, processed, and retailed by PharmaCann vertically.
2014Oak Park, Illinois, United StatesUSD 218.7 M–979
Consumer lawn and garden products and services are provided.
1868Columbus, Ohio, United States–USD 3.41 B5,300
Provider of cannabis dispensaries, cultivators, CPG brands, and services
–Denver, Colorado, United States–USD 172.45 M–
Provider of cannabis based medical and consumer products
2016New York, New York, United StatesUSD 13.78 MUSD 17.42 M–
Offers medical & wellness cannabis products sourcing and processing services
2021London, England, United KingdomUSD 5.32 MUSD 258.08 K168
Cannabis extracts and white label solutions are provided globally.
2016United StatesUSD 13.56 M––
Cannabis products are produced, cultivated, branded, and processed.
2017New York, New York, United States––2,198
Developer of water-soluble cannabinoid extraction technologies
2018Los Alamos, New Mexico, United StatesUSD 47.59 M––
Medicinal cannabis is produced by Blueberries Medical in Colombia.
2013Bogota, Bogota, Colombia–USD 228.08 K–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Invizyne

Invizyne was founded in 2014 and raised its 1st funding round 5 years after it was founded.

Invizyne is headquartered in Monrovia, United States. It is registered at Monrovia, California, United States.

Mo Hayat is the current CEO of Invizyne.

Invizyne has 16 employees.

Invizyne was founded in 2014 in Monrovia, United States. Enzymatic bioconversions are engineered by the company to synthesize cannabinoid products within the biotechnology sector. Synthetic biology methods are employed to facilitate efficient production processes. Operations are based in the United States, with focus on bioconversion technologies. Leadership is provided by CEO Mo Hayat, alongside co-founders Paul Opgenorth, Tyler Korman, and James Bowie.

Invizyne has 1 investor. Key investors include OSTI.GOV.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available